2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia

S.A. Factor, R.A. Hauser, S. Siegert, G.S. Liang, C.F. O'Brien (Atlanta, GA, USA)
Kinematic analysis of repetitive finger movements and the effects of selegiline and pramipexole in early Parkinson’s disease

G. Leodori, M. Bologna, P. Stirpe, G. Paparella, D. Belvisi, A. Fasano, G. Fabbrini, A. Berardelli (Rome, Italy)
L-dopa-responsive, diurnally fluctuating auricular tremor with tetrahydrobiopterin (BH4) deficiency

N.K. Iwata, H. Shintaku, S. Shibata, K. Takeda, J. Goto (Tokyo, Japan)
Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with idiopathic Parkinson’s disease

J.H. Hong, Y.K. Kim, J.S. Park, J.E. Lee, M.S. Oh, E.J. Chung, J.Y. Kim, Y.H. Sung, C.H. Lyoo, J.H. Lee, D.Y. Kwon, H.S. Kim, H.W. Shin, S.A. Park, I.S. Park, J.S. Kim, P.H. Lee, S.B. Koh, J.S. Baik, S.J. Kim, H.I. Ma, J.W. Kim, Y.J. Kim (Anyang, Korea)
Lance-Adams syndrome with post-hypoxic myoclonus- physiotherapy intervention

B. Cruz (Long Beach, CA, USA)
LC3 deacetylation by SIRT1 is involved in neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s disease

Y. Wu, Y. Guo, S. Dong, X. Cui, Y. Feng, W. Zhao (Shanghai, People's Republic of China)
Lead angle matters: Side effects of deep brain stimulation improved with adjustment of lead angle

M.H. Pourfar, A.Y. Mogilner (New York, NY, USA)
Lessons learned from the Nilotinib trial: Cardio-vascular conditions in parkinsonism

Y. Torres-Yaghi, A. Keys, V. Ellen, S. Ashot, M. Elizabeth, S. Justin, M. Charbel, P. Fernando (Washington, DC, USA)
Lessons-experienced in the creation of a global public-private consortium with the goal of advancing treatments that hold most potential for delayed disease progression in Parkinson’s disease – Critical path for Parkinson’s (CPP)

V.D. Kern, D.T. Stephenson, K. Romero, E. Avilés, S.T. Broadbent, S.P. Arneric, L. Barbieri, S. Ford, A. Roach (Tucson, AZ, USA)
Leukocyte perturbations suggest immune dysregulation in progressive supranuclear palsy

M.C. Schiess, J.O. Suescun, A. Actor, A. Gonzales, K.C. Smith (Houston, TX, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z